Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
GLMD

Overview Financials Analysis Smart Money

Galmed Pharmaceuticals Ltd.

GLMD · NASDAQ

Analyze with AI

Filings1

Total reported value$0.0

Manager	Shares	Value	Change
Advisor Group, Inc.	0	$0.0	+100.0%

SymbolGLMD

Market Cap$5.4M

IPO Date2014-03-13

CEOAllen Baharaff

Employees3

SectorHealthcare

IndustryBiotechnology

CountryIL

ExchangeNASDAQ Capital Market

Vision Marine Technologies Inc.

VMAR

$0.976

+156.77%

B. Riley Financial, Inc.

RILY

$5.72

+53.76%

Cementos Pacasmayo S.A.A.

CPAC

$10.64

+52.22%

Everbright Digital Holding Limited Ordinary Shares

EDHL

$0.5472

+43.40%

Adagio Medical Holdings, Inc.

ADGM

$1.18

+41.95%

Peers

BioVie Inc.

BIVI · NASDAQ

$1.43

+0.00%

Theriva Biologics, Inc.

TOVX · AMEX

$0.2068

+5.30%

Moolec Science S.A.

MLEC · NASDAQ

$0.3255

-11.60%

Chemomab Therapeutics Ltd.

CMMB · NASDAQ

$2.06

+0.00%

InMed Pharmaceuticals Inc.

INM · NASDAQ

$1.32

+9.58%

Biodexa Pharmaceuticals Plc

BDRX · NASDAQ

$6.50

+35.98%

Virax Biolabs Group Limited

VRAX · NASDAQ

$0.398

-2.93%

PMGC Holdings Inc.

ELAB · NASDAQ

$3.29

-0.76%

iSpecimen Inc.

ISPC · NASDAQ

$0.4084

-2.95%

NKGen Biotech, Inc. Common Stock

NKGN · NASDAQ

$0.047

-6.00%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.